ID   BT4Cn
AC   CVCL_S568
DR   Wikidata; Q54798502
RX   PubMed=1985868;
RX   PubMed=3178168;
RX   PubMed=3468291;
RX   PubMed=3731074;
CC   Doubling time: 26.7 +- 1.4 hours (Note=In serum-supplemented media), 38.7 +- 4.0 hours (Note=In serum-free media) (PubMed=3178168).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5712 ! BT4C
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
RX   PubMed=1985868; DOI=10.1002/ijc.2910470122;
RA   Andersson A.-M., Moran N., Gaardsvoll H., Linnemann D., Bjerkvig R.,
RA   Laerum O.D., Bock E.M.;
RT   "Characterization of NCAM expression and function in BT4C and BT4Cn
RT   glioma cells.";
RL   Int. J. Cancer 47:124-129(1991).
//
RX   PubMed=3178168;
RA   Akslen L.A., Andersen K.-J., Bjerkvig R.;
RT   "Characteristics of human and rat glioma cells grown in a defined
RT   medium.";
RL   Anticancer Res. 8:797-803(1988).
//
RX   PubMed=3468291; DOI=10.1093/jnci/78.2.279;
RA   Bjerknes R., Bjerkvig R., Laerum O.D.;
RT   "Phagocytic capacity of normal and malignant rat glial cells in
RT   culture.";
RL   J. Natl. Cancer Inst. 78:279-288(1987).
//
RX   PubMed=3731074;
RA   Bjerkvig R., Laerum O.D., Mella O.;
RT   "Glioma cell interactions with fetal rat brain aggregates in vitro and
RT   with brain tissue in vivo.";
RL   Cancer Res. 46:4071-4079(1986).
//